Skip to main content
. 2021 Apr 8;93(7):4405–4410. doi: 10.1002/jmv.26985

Table 1.

Demographic, clinical, and laboratory characteristics study patients with paired RT‐PCR and RAD

Any RAD Panbio Eco p
Gender (male), N % 52, 46% 25, 57% 27, 40% .09
Age (years) 40 (IQR: 31–56) 47.9 (IQR: 30–62) 39.4 (IQR: 31–54) .36
Symptoms (days) 4 (IQR: 3–6) 4 (IQR: 3–5) 4 (IQR: 2–6) .90
RNA detected (RT‐qPCR) 31/108, 28% 9/42, 21% 22/66, 32% .30
Antigen detected (RAD) 31/112, 28% 11/44, 25% 20/68, 29% .67
Concordance 101/108, 96% 40/42, 96% 61/66, 97% .70
Sensitivity (%) 87 (95% CI: 70–96) 100 (95% CI: 66–100) 82 (95% CI: 60–95)
Specificity (%) 96 (95% CI: 89–99) 94 (95% CI: 80–99) 98 (95% CI: 88–100)

Note: Continuous variables presented as median and interquartile range (IQR) and categorical variables as proportions. p Value calculated using the Mann–Whitney U test for continuous variables and the χ 2 test, or Fisher's exact test for categorical variables.

Abbreviations: CI, confidence interval; COVID‐19, coronavirus disease 2019; IQR, interquartile range; RAD, rapid antigen detection (COVID‐19 Ag ECO Test [Eco] and PanbioTM COVID‐19 Ag Rapid Test Abbott [Panbio]); RT‐PCR, reverse transcription polymerase chain reaction; RT‐qPCR, quantitative RT‐PCR.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.